Nonsurgical management of pancreaticopleural fistula

JOP. 2005 Mar 10;6(2):152-61.

Abstract

Context: Pancreaticopleural fistula is seen in acute and chronic pancreatitis or after traumatic or surgical disruption of the pancreatic duct. Surgery leads to healing in 80-90% of cases but carries a mortality of up to 10%.

Aim: Our aim was to assess the management of pancreaticopleural fistula on a specialist pancreatic Unit.

Methods: Patients presenting with pancreaticopleural fistulae were identified from acute and chronic pancreatitis databases. Management and outcome were compared with previous studies identified in MEDLINE and EMBASE.

Results: Four patients presented with dyspnoea from large unilateral pleural effusions. Three had a history of alcohol abuse and one of asymptomatic gallstones. All were treated with chest drainage, octreotide and endoscopic retrograde cholangiopancreatography plus/minus pancreatic stent. Two had a pancreatic stent in situ for 5 and 8.5 months respectively. In the third sphincterotomy was performed; in the fourth the pancreatic duct could not be cannulated. The fistula healed in all cases, with no recurrence after 12-30 months, and no deaths. There are 14 reports including 16 cases treated with endoscopic retrograde cholangiopancreatography plus/minus pancreatic stent in the literature, with no recurrence after follow up ranging 4-30 months and no deaths in these 16 cases.

Conclusions: A high index of suspicion is necessary to be aware of its presence. These data suggest that endoscopic management is preferable alternative to surgery for pancreaticopleural fistula.

Publication types

  • Case Reports

MeSH terms

  • Chest Tubes
  • Cholangiopancreatography, Endoscopic Retrograde / methods*
  • Combined Modality Therapy
  • Drainage / methods*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*
  • Pancreatic Fistula / diagnosis
  • Pancreatic Fistula / mortality
  • Pancreatic Fistula / therapy*
  • Pleural Effusion / diagnosis
  • Pleural Effusion / mortality
  • Pleural Effusion / therapy*
  • Respiratory Tract Fistula / diagnosis
  • Respiratory Tract Fistula / mortality
  • Respiratory Tract Fistula / therapy*
  • Stents*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Octreotide